- About Us
- Advertise
- Contact Us
- CureToday.com
- CancerNetwork.com
- OncLive.com
- Do Not Sell My Information
- Privacy
- Terms & Conditions
© 2021 MJH Life Sciences™ , Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways. All rights reserved.
Keith C. Bible, MD, PhD | Authors
Articles
Dr. Keith C. Bible on Treatments Beyond First-Line Lenvatinib in Thyroid Cancer
March 11, 2016
Video
Bible says most oncologists would consider lenvatinib as a first-line therapy for patients who require systemic therapy where there are not suitable, focal palliative options.
The Challenges of Treating Follicular Cell-Derived Thyroid Carcinoma
January 28, 2015
Article
Keith C. Bible, MD, PhD, professor of oncology, Mayo Clinic, discusses the challenges associated with treating patients with follicular cell-derived thyroid carcinoma.